Outcomes following reirradiation of patients with heap and neck cancer

Head and Neck

Volumn 30, Issue 6, 2008, Pages 765-770

  Goldstein, David P ^a   Karnell, Lucy Hynds ^b   Yao, Min ^b   Chamberlin, G Parker ^b   Nguyen, Thanh X ^b   Funk, Gerry F ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Head and neck cancer; Radiation related toxicity; Recurrent cancer; Reirradiation; Survival outcomes

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HEAD AND NECK CANCER; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LARYNX CANCER; MALE; MOUTH CANCER; PHARYNX CANCER; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE; RETREATMENT; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA;

AGED; CARCINOMA; COHORT STUDIES; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PALLIATIVE CARE; RADIOTHERAPY; RETREATMENT; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 46249097172     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.20786     Document Type: Article

References (35)

1. Gilbert H, Kagan AR. Recurrence patterns in squamous cell carcinoma of the oral cavity, pharynx, and larynx. J Surg Oncol 1974;6:357-380.
2. Hong WK, Bromer RH, Amato DA, et al. Patterns of relapse in locally advanced head and neck cancer patients who achieved complete remission after combined modality therapy. Cancer 1985;56:1242-1245.
3. Williams RG. Recurrent head and neck cancer: the results of treatment. Br J Surg 1974;61:691-697.
4. Yuen AP, Ho CM, Wei WI, Lam LK. Analysis of recurrence after surgical treatment of advanced laryngeal carcinoma. J Laryngol Otol 1995;109:1063-1067.
5. Garofalo MC, Haraf DJ. Reirradiation: a potentially curative approach to locally or regionally recurrent head and neck cancer. Curr Opin Oncol 2002;14:330-333.
6. Arnold DJ, Goodwin WJ, Weed DT, Civantos FJ. Treatment of recurrent and advanced stage squamous cell carcinoma of the head and neck. Semin Radiat Oncol 2004; 14:190-195.
7. Kasperts N, Slotman B, Leemans CR, Langendijk JA. A review on re-irradiation for recurrent and second primary head and neck cancer. Oral Oncol 2005;41:225-243.
8. Goodwin WJ Jr. Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: when do the ends justify the means? Laryngoscope 2000;110:1-18.
9. Machtay M, Rosenthal DI, Chalian AA, et al. Pilot study of postoperative reirradiation, chemotherapy, and ami-fostine after surgical salvage for recurrent head-and-neck cancer. Int J Radiat Oncol Biol Phys 2004;59:72-77.
10. Kao J, Garofalo MC, Milano MT, Chmura SJ, Citron JR, Haraf DJ. Reirradiation of recurrent and second primary head and neck malignancies: a comprehensive review. Cancer Treat Rev 2003;29:21-30.
11. Dawson LA, Myers LL, Bradford CR, et al. Conformal re-irradiation of recurrent and new primary head-and-neck cancer. Int J Radiat Oncol Biol Phys 2001;50:377-385.
12. Eisbruch A, Dawson L. Re-irradiation of head and neck tumors. Benefits and toxicities. Hematol Oncol Clin North Am 1999;13:825-836.
13. De Crevoisier R, Bourhis J, Domenge C, et al. Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients. J Clin Oncol 1998;16:3556-3562.
14. Stevens KR Jr, Britsch A, Moss WT. High-dose reirradiation of head and neck cancer with curative intent. Int J Radiat Oncol Biol Phys 1994;29:687-698.
15. De Crevoisier R, Bourhis J, Eschwege F. Modified fractionated radiotherapy in head and neck squamous cell carcinoma (HNSCC) and re-irradiation in recurrent head and neck carcinomas. Cancer Treat Res 2003;114:199-212.
16. Haraf DJ, Weichselbaum RR, Vokes EE. Re-irradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer: a potentially curable disease. Ann Oncol 1996;7:913-918.
17. Emami B, Bignardi M, Spector GJ, Devineni VR, Hederman MA. Reirradiation of recurrent head and neck cancers. Laryngoscope 1987;97:85-88.
18. Emami B, Marks JE. Retreatment of recurrent carcinoma of the head and neck by afterloading interstitial 192Ir implant. Laryngoscope 1983;93:1345-1347.
19. Stewart FA. Re-treatment after full-course radiotherapy: is it a viable option? Acta Oncol 1999;38:855-862.
20. Skolyszewski J, Korzeniowski S, Reinfuss M. The reirradiation of recurrences of head and neck cancer. Br J Radiol 1980;53:462-465.
21. Chmura SJ, Milano MT, Haraf DJ. Reirradiation of recurrent head and neck cancers with curative intent. Semin Oncol 2004;31:816-821.
22. Creak AL, Harrington K, Nutting C. Treatment of recurrent head and neck cancer: re-irradiation or chemotherapy? Clin Oncol (R Coll Radiol) 2005;17:138-147.
23. Ohizumi Y, Tamai Y, Imamiya S, Akiba T. Prognostic factors of reirradiation for recurrent head and neck cancer. Am J Clin Oncol 2002;25:408-413.
24. Spencer SA, Harris J, Wheeler RH, et al. RTOG 96-10: reirradiation with concurrent hydroxyurea and 5-fluo-rouracil in patients with squamous cell cancer of the head and neck. Int J Radiat Oncol Biol Phys 2001;51: 1299-1304.
25. Spencer SA, Wheeler RH, Peters GE, et al. Concomitant chemotherapy and reirradiation as management for recurrent cancer of the head and neck. Am J Clin Oncol 1999;22:1-5.
26. De Crevoisier R, Domenge C, Wibault P, et al. Full dose reirradiation combined with chemotherapy after salvage surgery in head and neck carcinoma. Cancer 2001;91: 2071-2076.
27. Ang KK, Jiang GL, Feng Y, Stephens LC, Tucker SL, Price RE. Extent and kinetics of recovery of occult spinal cord injury. Int J Radiat Oncol Biol Phys 2001;50:1013-1020.
28. Forastiere AA. Overview of platinum chemotherapy in head and neck cancer. Semin Oncol 1994;21:20-27.
29. Vokes EE, Athanasiadis I. Chemotherapy of squamous cell carcinoma of head and neck: the future is now. Ann Oncol 1996;7:15-29.
30. Clavel M, Vermorken JB, Cognetti F, et al. Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck. A phase III study of the EORTC Head and Neck Cancer Cooperative Group. Ann Oncol 1994;5:521-526.
31. Forastiere AA, Metch B, Schuller DE, et al. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squa-mous-cell carcinoma of the head and neck: a Southwest Oncology Group study. J Clin Oncol 1992;10:1245-1251.
32. Jacobs C, Lyman G, Velez-Garcia E, et al. A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. J Clin Oncol 1992;10:257-263.
33. Jacobs C, Meyers F, Hendrickson C, Kohler M, Carter S. A randomized phase III study of cisplatin with or without methotrexate for recurrent squamous cell carcinoma of the head and neck. A Northern California Oncology Group study. Cancer 1983;52:1563-1569.
34. Wang CC. Re-irradiation of recurrent nasopharyngeal carcinoma-treatment techniques and results. Int J Radiat Oncol Biol Phys 1987;13:953-956.
35. Pomp J, Levendag PC, van Putten WL. Reirradiation of recurrent tumors in the head and neck. Am J Clin Oncol 1988;11:543-549.